
What We Do
Our work in context
What are genetic technologies?
Genetic technologies range from at home genetic test kits, to gene editing tools such as CRISPR, to the cultivation of stem cells from reprogrammed skin or blood cells.
Big decisions: 2018 - 2020
First genetically modified children are born
Stem Cells created from reprogrammed skin and blood cells
Human germ-line edited for the first time
First three-parent IVF baby is born
Every newborn child in the UK will have their genome sequenced
Genetic technology has huge potential, but comes with considerable risks. The aim of our work is to ensure those risks are given proper consideration, and that genetic technologies are used for the good of humanity as a whole.
Genetic technology has huge potential, but what are the risks?
Gene Editing: what are the risks?
In 2018, a Chinese researcher named He Jiankui used the gene editing tool CRISPR in an attempt to make two twins genetically resistant to HIV. The first genetically modified humans were born.
Many other countries have taken steps leading towards the birth of the first genetically modified humans. This was also the first time that the human germline was modified.
When alterations are made to the human germline, the genome of an individual is edited in such a way that the change is heritable. The alterations will be passed onto the next generation. Although gene editing tools like CRISPR are very precise, mistakes that are made - any unintentional edits - will affect how genes function. Potentially creating mutations and new diseases that could spread throughout the population.
Aside from the risks, editing human genes raises ethical concerns, including:
Should we enhance human biological make-up?
Unequal access
How will personal genomic data be used in the future?
Designer babies
What are the benefits?
Genome sequencing - the process of determining the complete DNA sequence held on each of our genomes - could hold the key to improving our understanding of a range of diseases. Analysing someone’s genome can also reveal their chances of developing certain debilitating or terminal illnesses, and help in developing personalised treatments based on genetic factors.
Similarly, gene editing - the manipulation of DNA and modification of genes - could one day be used to protect people from a variety of hereditary conditions, such as cystic fibrosis, sickle cell anemia, genetic blindness, AIDS, and muscular dystrophy.
Genome Sequencing: what are the risks?
Our DNA can be predictive of our genetic predispositions, as well as those of our family members - extending over generations. A genome is inheritable, and unique. It is not possible to make it anonymous.
In many countries across the world, governments are sequencing and storing the genome profiles of their citizens. This will improve our understanding of a range of diseases, and eventually help find treatments for them. As corporations are also amassing vast databases of personal genome data, how might this data be used in the future?
Life insurers have already made the disclosure of any previous genetic tests obligatory. Employers or educational institutions could make genetic tests part of their own evaluations of candidates. As for how genomic data might be used and what decisions will be taken about us, the mass surveillance by government agencies of their own citizens is a chilling reminder of the way information technology can be used.
What are the ethical issues?
Some of the scientists responsible for creating gene editing technologies worry that these technologies will be used to select specific traits. Eventually, it will be possible to enhance those traits, and to choose the genetic makeup of children, leading to ‘designer babies’.
If richer members of society are able to afford genetic technologies, those who can’t may be left behind.
Inequality of access to genetic technologies could deepen social inequalities.
What is needed?
A New Social Contract for Genetic Technology
The genetic technology sector has become the focus of the economic policies of governments. Big decisions are being taken by a small group of people who often have vested interests, including government officials and those working in life sciences. Because of the increasingly commercial agenda of governments and big business, the public might struggle to stay involved in decision-making.
We believe there should be a social contract for the use of genetic technologies, to give the public a say in whether, and how, these technologies are used.
This social contract would exist between genetic technology companies, governments and the public, and would support better regulation, and better, more public-centered, policy decisions.
Without one, we run the risk of giving governments and corporations too much power over the millions of genomic profiles they are collecting. If only wealthy people have access to gene editing technologies, then this could create previously unseen levels of inequality.
A truly public bioscience will ensure we don’t lose control over our genetic futures
Governments / Genetic technology industry should:
Pledge 1% of their spending for genetic technologies on a Truly Public bioscience:
Educating the public about genetic technologies: the science, risks and ethics
Conducting nationwide, ongoing, public consultations so the public are given a say when deciding if, and how, we use genetic technologies
A New Social Contract for Genetic Technology, begins with you.
Become part of this.
Sign our petition
Share our call for a new social contract
Like our Facebook Page
ollow us on Twitter
Share our website on Twitter
Share our campaign on Instagram